Editorial. Considering the role of surgery for low-grade glioma in the molecular genetic era

View More View Less
  • Department of Neuro-Oncology, Moffitt Cancer Center, Tampa, Florida
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

If the inline PDF is not rendering correctly, you can download the PDF file here.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Correspondence Michael A. Vogelbaum: michael.vogelbaum@moffitt.org.

ACCOMPANYING ARTICLE DOI: 10.3171/2019.6.JNS19972.

INCLUDE WHEN CITING Published online October 25, 2019; DOI: 10.3171/2019.7.JNS191747.

Disclosures The author has indirect equity and royalty interests in Infuseon Therapeutics, Inc., and he has received honoraria in the past 12 months from Celgene, Tocagen, and Blue Earth Diagnostics.

  • 1

    Aghi MK, Nahed BV, Sloan AE, Ryken TC, Kalkanis SN, Olson JJ: The role of surgery in the management of patients with diffuse low grade glioma: a systematic review and evidence-based clinical practice guideline. J Neurooncol 125:503530, 2015

    • Search Google Scholar
    • Export Citation
  • 2

    Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, : IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 16:8191, 2014

    • Search Google Scholar
    • Export Citation
  • 3

    Brennum J, Maier CM, Almdal K, Engelmann CM, Gjerris M: Primo non nocere or maximum survival in grade 2 gliomas? A medical ethical question. Acta Neurochir (Wien) 157:155164, 2015

    • Search Google Scholar
    • Export Citation
  • 4

    Chaichana KL, McGirt MJ, Laterra J, Olivi A, Quiñones-Hinojosa A: Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. J Neurosurg 112:1017, 2010

    • Search Google Scholar
    • Export Citation
  • 5

    de Leeuw CN, Vogelbaum MA: Supratotal resection in glioma: a systematic review. Neuro Oncol 21:179188, 2019

  • 6

    Duffau H: Diffuse low-grade glioma, oncological outcome and quality of life: a surgical perspective. Curr Opin Oncol 30:383389, 2018

  • 7

    Duffau H: Is supratotal resection of glioblastoma in noneloquent areas possible? World Neurosurg 82:e101e103, 2014

  • 8

    Grabowski MM, Recinos PF, Nowacki AS, Schroeder JL, Angelov L, Barnett GH, : Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma. J Neurosurg 121:11151123, 2014

    • Search Google Scholar
    • Export Citation
  • 9

    Kavouridis VK, Boaro A, Dorr J, Cho EY, Iorgulescu JB, Reardon DA, : Contemporary assessment of extent of resection in molecularly defined categories of diffuse low-grade glioma: a volumetric analysis. J Neurosurg [epub ahead of print October 25, 2019. DOI: 10.3171/2019.6.JNS19972]

    • Search Google Scholar
    • Export Citation
  • 10

    Keles GE, Lamborn KR, Berger MS: Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome. J Neurosurg 95:735745, 2001

    • Search Google Scholar
    • Export Citation
  • 11

    Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, : A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190198, 2001

    • Search Google Scholar
    • Export Citation
  • 12

    Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, : The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131:803820, 2016

    • Search Google Scholar
    • Export Citation
  • 13

    McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A: Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463470, 2009

    • Search Google Scholar
    • Export Citation
  • 14

    Pallud J, Varlet P, Devaux B, Geha S, Badoual M, Deroulers C, : Diffuse low-grade oligodendrogliomas extend beyond MRI-defined abnormalities. Neurology 74:17241731, 2010

    • Search Google Scholar
    • Export Citation
  • 15

    Roelz R, Strohmaier D, Jabbarli R, Kraeutle R, Egger K, Coenen VA, : Residual tumor volume as best outcome predictor in low grade glioma - a nine-years near-randomized survey of surgery vs. biopsy. Sci Rep 6:32286, 2016

    • Search Google Scholar
    • Export Citation
  • 16

    Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. J Neurosurg 115:38, 2011

    • Search Google Scholar
    • Export Citation
  • 17

    Vogelbaum MA, Jost S, Aghi MK, Heimberger AB, Sampson JH, Wen PY, : Application of novel response/progression measures for surgically delivered therapies for gliomas: Response Assessment in Neuro-Oncology (RANO) Working Group. Neurosurgery 70:234244, 2012

    • Search Google Scholar
    • Export Citation
  • 1

    Beiko J, Suki D, Hess KR, Fox BD, Cheung V, Cabral M, : IDH1 mutant malignant astrocytomas are more amenable to surgical resection and have a survival benefit associated with maximal surgical resection. Neuro Oncol 16:8191, 2014

    • Search Google Scholar
    • Export Citation
  • 2

    Cote DJ, Barnett I, Onnela JP, Smith TR: Digital phenotyping in patients with spine disease: a novel approach to quantifying mobility and quality of life. World Neurosurg 126:e241e249, 2019

    • Search Google Scholar
    • Export Citation
  • 3

    Englot DJ, Berger MS, Barbaro NM, Chang EF: Predictors of seizure freedom after resection of supratentorial low-grade gliomas. A review. J Neurosurg 115:240244, 2011

    • Search Google Scholar
    • Export Citation
  • 4

    Iorgulescu JB, Torre M, Harary M, Smith TR, Aizer AA, Reardon DA, : The misclassification of diffuse gliomas: rates and outcomes. Clin Cancer Res 25:26562663, 2019

    • Search Google Scholar
    • Export Citation
  • 5

    Torous J, Staples P, Shanahan M, Lin C, Peck P, Keshavan M, : Utilizing a personal smartphone custom app to assess the Patient Health Questionnaire-9 (PHQ-9) depressive symptoms in patients with major depressive disorder. JMIR Ment Health 2:e8, 2015

    • Search Google Scholar
    • Export Citation
  • 6

    Xu DS, Awad AW, Mehalechko C, Wilson JR, Ashby LS, Coons SW, : An extent of resection threshold for seizure freedom in patients with low-grade gliomas. J Neurosurg 128:10841090, 2018

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 311 311 167
Full Text Views 123 123 85
PDF Downloads 79 79 60
EPUB Downloads 0 0 0